 The same panel is used in the Molecular Target Program for the characterization of molecular targets.Measurements include protein levels, RNA measurements, mutation status and enzyme activity levels.The panel holds cell lines representing leukemia, melanoma, non-small-cell lung carcinoma, and cancers of the brain, ovary, breast, colon, kidney, and prostate.